Svmuu reports that the review of the "Cryptocurrency Market Structure Bill" (the CLARITY Act) has begun in the U.S. Senate Banking Committee, sparking intense conflict over a key amendment concerning ethical constraints on senior government officials. Proposed by Senator Chris Van Hollen, the amendment aimed to prohibit senior government officials, including the President and Vice President, from having commercial interests in the crypto industry and to strengthen transparency requirements. In his remarks, he stated that the provision was designed to prevent conflicts of interest and self-dealing, and specifically mentioned the connection between Trump, his family, and World Liberty Financial.
Senator Bernie Moreno opposed the amendment, arguing that it includes criminal penalty clauses, making it "outside the scope of the Banking Committee's review" and more suitable for the Judiciary Committee. He also criticized Van Hollen's use of the term "corruption," stating that making criminal accusations against individuals without evidence was inappropriate. Ultimately, the amendment was rejected with 11 votes in favor and 13 against, failing to pass.
CLARITY Bill Hearing Live: Ethics Amendment Rejected, Senate Clashes Over Conflict of Interest Issues
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
3
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
4
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
5
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
6
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
7
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
8
MARA Stock Valuation Analysis: Marathon Digital Holdings’ Transition to AI and Long-Term Investment Outlook
-
9
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
10
NVIDIA and AMD: The Two Giants of AI Computing Power in 2026—An Analysis of Market Dynamics, Financial Performance, and Opportunities for Transition into Cryptocurrency Mining
Markets Today
Recommended Reading










